Why the study?
This review was conducted to highlight current knowledge on the crosstalk between exosomes and lipid metabolism and their impact on cardiometabolic disease.
Key points are not available for this paper at this time.
Design
Review
Exosome-lipid interplay may guide cardiometabolic biomarker development; leaves open therapeutic validation in prospective trials.
PURPOSE OF REVIEW: Exosomes are lipid-bound particles that carry lipids, protein, and nucleic acid and affect cellular function. This review highlights the current knowledge on the crosstalk between exosomes and lipid metabolism and their impact on cardiometabolic disease. RECENT FINDINGS: Recent studies revealed that lipids and lipid metabolizing enzymes are important for exosome biogenesis and internalization and conversely how exosomes affect lipid metabolism, secretion, and degradation. The interplay between exosomes and lipid metabolism affects disease pathophysiology. More importantly, exosomes and lipids might function as biomarkers for diagnosis and prognosis or possibly therapies. SUMMARY: Recent advances in our understanding of exosomes and lipid metabolism have implications for our understanding of normal cellular and physiological functions as well as disease pathogenesis. Exosome and lipid metabolism have implications in novel diagnostic tests and treatments of cardiometabolic disease.
No takes yet. Share an insight, caveat, or question.
Abdin et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: